ArticleScientific reports2024

CIGB-300 internalizes and impairs viability of NSCLC cells lacking actionable targets by inhibiting casein kinase-2 signaling.

Ying Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.